Austria Antihypertensive Medicine Sales is set to reach $59.46 Million by 2026 from $58.52 Million 2021, increased 1.7% per year. The country ranked number 6 in 2021, Canada overtook $58.52 Million. Italy, Spain and Australia respectively ranked numbers 2, 3 and 4 in this ranking.
How does Austria rank in Antihypertensive Medicine Sales?
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 357.2 | 2023 | +0.056% | -0.89% | View data |
| 2 | 2 Italy | 177.4 | 2023 | +1.03% | -3.31% | View data |
| 3 | 3 Australia | 162.2 | 2023 | +10.79% | +13.35% | View data |
| 4 | 4 Austria | 56.8 | 2023 | +0.53% | +1.05% | |
| 5 | 5 Sweden | 32.6 | 2023 | +7.95% | +5.04% | View data |
| 6 | 6 Chile | 8.3 | 2023 | +3.75% | -5.3% | View data |
